|
Class 2 Device Recall CrAg Lateral Flow Assay |
|
Date Initiated by Firm |
January 03, 2022 |
Create Date |
January 31, 2022 |
Recall Status1 |
Terminated 3 on May 15, 2024 |
Recall Number |
Z-0545-2022 |
Recall Event ID |
89370 |
510(K)Number |
K112422
|
Product Classification |
Antisera, latex agglutination, cryptococcus neoformans - Product Code GMD
|
Product |
CRYPTOCOCCAL ANTIGEN LATERAL FLOW ASSAY, IMMY, Lateral Flow Assay for the Detection of Cryptococcal Antigen in serum and CSF, REF CR2003, IVD, UDI: (01)00816387020919 |
Code Information |
F1021035 and F1021036 |
Recalling Firm/ Manufacturer |
Immuno-Mycologics, Inc 2701 Corporate Centre Dr Norman OK 73069-2901
|
For Additional Information Contact |
Joy Pelfrey 405-364-1058
|
Manufacturer Reason for Recall |
The firm found immunoassay products used to detect cryptococcal antigen in serum and cerebrospinal fluid to have reduced specificity (90% now versus 99% before). As a result, a small number of samples with positive test results may be false positives, which may cause some patients to initiate unnecessary anti-fungal therapy. Samples with negative test results are NOT affected.
|
FDA Determined Cause 2 |
Material/Component Contamination |
Action |
Customers who received product were contacted via letter Urgent: Medical Device Recall, Cryptococcal Antigen Lateral Flow Assay, dated January 3, 2022, beginning January 3, 2022, to locate and immediately destroy their affected devices. A recall notification and response form was attached to the email that is to be completed by the customers and returned to the firm. |
Quantity in Commerce |
411 kits |
Distribution |
US Nationwide distribution in the states of AL, AR, AZ, CA, CO, CT, FL, GA, IL, IN, KY, LA, MA, MI, MN, MO, MS, NC, ND, NE, NH, NJ, NM, NY, OH, OR, PA, RI, SC, TN, TX, UT, VA, WA.
|
Total Product Life Cycle |
TPLC Device Report
|
|
1 A record in this database is created when a firm initiates a correction or removal action. The record is updated if the FDA identifies a violation and classifies the action as a recall, and it is updated for a final time when the recall is terminated. Learn more about medical device recalls.
2 Per FDA policy, recall cause determinations are subject to modification up to the point of termination of the recall.
3 For details about termination of a recall see Code of Federal Regulations (CFR) Title 21 §7.55.
|
510(K) Database |
510(K)s with Product Code = GMD and Original Applicant = IMMUNO-MYCOLOGICS, INC.
|
|
|
|